Introduction. Treatment of neurological diseases usually requires polypharmacy, and it is crucial to detect potential drug-drug interactions (DDIs) and recognize risk factors in timely manner, as consequences of DDIs could be serious. The aim of our study was to analyze risk factors for occurrence and number of potential drug-drug interactions among patients. Methods. This study was conducted in 144 inpatients in general-care neurological department of a tertiary care hospital. Effects of risk factors for potential DDIs were evaluated by multiple linear regression. The study had retrospective cohort design. Frequencies of various types of potential DDIs (according to severity) discovered by Medscape, Epocrates and Micromedex online interaction checkers. Results. Number of prescribed drugs, age of a patient, value of the Charlson comorbidity index and prescription of an antidepressant increase risk of potential DDIs in a general neurology ward. On the other hand, being paralyzed, number of prescribers for a single patient, being bedridden for at least one day of hospitalization decreased number of potential DDIs per patient. Number of prescribed drugs per patient (OR=1.466±0.250; p=0.000) and age (OR=1.027±0.026; p=0.041) increased, and number of prescribers per patient (OR=0.056±0.028; p=0.016), especially if the patients were paralyzed (OR=0.214±0.294; p=0.007), decreased risk of contraindicated, serious, "use alternative" or major potential DDIs. Antidepressant increase risk of absolute number of all monitor/modify potential DDIs (OR=1.257±0.726; p=0.035).
Primena antidepresiva povećava rizik za nastanak "prati/promeni" interakcija (OR=1.257±0.726; p=0.035). Zakljucak. Ucestalost potencijalnih interakcija izmedju
Introduction
Drug-drug interaction (DDI) could be defined as a change of a drug action when it is taken together with another drug/drugs, in terms of intensity of action, pharmacokinetic attributes or occurrence of adverse drug effects (1) . Early recognition of potential DDIs gives an opportunity to prevent them, what is significant not only from healthcare provider but also from a patient point of view. Since polypharmacy is unavoidable in modern management of 5 many diseases, creating an environment for occurrence DDIs, there is growing concern that interactions will lead to increased utilization of healthcare resources (e.g. outpatient visits, number and length of hospitalizations, etc.) within a health system, accompanied with increased costs (2, 3) . It was already shown that DDIs had a significant role in increased morbidity and mortality among hospitalized patients (4) . Discovery of potential DDIs is nowadays much easier with use of online or offline interaction checkers which classify interactions according to severity, like Medscape (5), Epocrates (6) and Micromedex (7) .
Drug-drug interactions on Medscape could be characterized as: contraindicated which means that this combination of drugs should not be used due to high risk for dangerous interaction; serious which indicate that this combination of drugs has potential for serious interaction and regular monitoring by doctor is required or alternate medication may be needed; than significant which indicate that potential for significant interaction is high and monitoring by doctor is likely required) and minor where interaction is unlikely, minor, or nonsignificant (8).
On Epocrates platform DDIs are organized according to clinical management and involve different categories such as "Contraindicated," "Avoid/Use Alternative," "Monitor/Modify Tx," and "Caution Advised" are. These categories are not intended to point severity of proposed interactions so every described interaction even "Caution Advised" interactions may have serious clinical consequences and should not be dismissed categorically (9 outcomes or increase severity of patients' status. In spite of these facts, interaction checkers differ in sensitivity or specificity, so due to inconsistencies health professionals should use more than one of them in practice. Also, some of these applications are free of charge and some of them require payment which may limit their wide use (11) .
The incidence of DDIs positively correlates with multiple, concurrent use of drugs and varies from 3-5%, if a patient takes a few drugs, to 20% in patients taking more than 10 drugs (12, 13) . Other risk factors which significantly contribute to the occurrence of DDIs are advanced age, co-morbidities, weak coordination of healthcare for individual patients among health professionals of various specialties, non-adherence of patients, etc. (14) .
Neurological patients are not an exception in terms of occurrence of DDIs. Treatment of neurological diseases usually requires polypharmacy, and it is crucial to recognize risk factors, detect potential drug-drug interactions in a timely manner and prevent additional deterioration of health in these complex patients (15) . It has been shown recently that the advanced age of patients and the number of prescribed drugs are risk factors for the occurrence of DDIs in neurological patients (16) . Neurological diseases are among the most common reasons for hospitalization in modern society. A study in Italy showed that the prevalence of drug-drug interaction in neurology ward was very similar to that in the internal medicine ward (16) . Dementia, for example, is a disease in expansion due to longer human life in new days (17) . Also, there was the result that nonvascular disease such as epilepsy increases the risk of DDIs in patients in neurology ward (15) . It is known that antiepileptic drugs have a lot of behavioral side effects including depression, aberrant behaviors, and the development or worsening of irritability, impulsivity, anger, hostility, and aggression (18) . Neurological patients are frequently disabled, sometimes bedridden or out of control of their sphincters. When hospitalized, they frequently develop urinary or respiratory tract infections, requiring the prescription of antibiotics, which increases overall medication burden and predisposes to DDIs. All these give certain specificity to drug-drug interactions problem in a neurology ward.
7
The aim of our study was to analyze risk factors for occurrence and number of potential drug-drug interactions among the patients admitted to general-care neurological department of a tertiary care hospital.
Methods
The study was approved by the Ethics Committee of Clinical Center Kragujevac (number of approval: N-0 l /14886). Our study was retrospective analysis ofpatient cohort treated at 
Results
In total there were 144 inpatients who participated in the study. Mean age of hospitalized patients was 59.0 ± 1.4, and median number of prescribed drugs per patient was 7 (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) .
The most common co-morbidity was hypertension (55.6%). The most common reason for admission was diagnostic evaluation of patients with neurological symptoms like headache or vertigo (34.7%). Outcome of hospitalization for majority of patients (89.6%) was discharge for further treatment at home. According to the Medscape interaction checker, potential contraindicated and serious-use alternative DDIs were found in 49.5% of patients, while median number of potential "monitor closely" DDIs per patient was 3 (0 -26).
Epocrates interaction checker discovered potential contraindicated or "use alternative"
DDIs in more than half of the patients (53.5%), and median number of potential Characteristics of the study sample. Results of multivariate analysis for the outcomes presence of potential contraindicated, serious, "use alternative" or major DDIs and absolute number of "monitor closely", "monitor/modify" or moderate DDI-s are presented in the Tables 2. and 3., respectively.
Variables included in both logistic and multiple linear regression were: age of patients, gender, length of hospitalization, main diagnosis at admission, number of prescribed drugs, number of pharmacological/therapeutic subgroups prescribed (2nd level of ATC classification), number of prescribers for a single patient, cognitive incompetence (delirium or dementia), Charlson co-morbidity index, paralysis, being bedridden for at least for one day of hospitalization, and receiving anticonvulsants, antidepressants or anticoagulants. Table 2 . There were 80 patients having diagnosis of hypertension in our sample, and among them we found 50 patients (ten with mild to moderate renal failure) with contraindicated or serious-use alternative/major potential drug-drug interactions. Frequency of contraindicated potential DDIs were 10 % (between two different non-steroidal anti-inflammatory drugs)
Multivariate regression analysis (binary logistic regression) for the outcome presence
while frequency of serious-use alternative/major potential DDIs were 96 % (between nonsteroidal anti-inflammatory drugs and angiotensin-converting enzyme inhibitors), Table 4 . 
Discussion
Results from our study showed that a number of prescribed drugs, an age of a patient, a value of the Charlson comorbidity index and prescription of an antidepressant increase risk of potential DDIs in a general neurology ward. On the other hand, being paralyzed, a number of prescribers for a single patient, being bedridden for at least one day of hospitalization decrease number of potential DDIs per patient. There are differences in sensitivity and specificity of available interaction checkers. Micromedex is rated as the most specific in general and the most sensitive for serious potential DDIs, while Epocrates and Medscape share the second place (11) . Accordingly, we revealed in our study the largest number contraindicated, serious, "use alternative" or major potential DDIs using Micromedex while the Medscape pointed to the largest number of "monitor closely", "monitor/modify" or moderate potential drug-drug interactions. Routine use of these interaction checkers could provide better care of these patients especcially due to prompt access to these Internet platforms. From the other side, complete set of information about consequences of potential DDIs and final descicion about final outcome of therapy could be summarized in the presence of other informations derived as from medical and practical knowledge as also from medical records of patients (20, 21) . Neurological disorders are one of the most common reasons for treatment in hospital facilities in modern society (16) . It is known that neurological disease has chronic and progressive clinical course and due these reasons patients in neurological ward needed to be treat mostly with more than one drug.
Polypharmacy increases risk of development of potential drug-drug interactions which can contribute to deterioration of primary medical condition of neurological patients (15) . Our results shown that the most frequently prescribed drugs were anticonvulsants, anticoagulant drugs, antidepressants, antiarrhythmic medicines, NSAIL and ACE inhibitors. These different groups of drugs have ability to increase possibility of development of clinically relevant drugdrug interactions and due this reason, neurological patients are more vulnerable population regarding DDIs and require special concern in detecting potential drug-drug interactions in a timely manner and preventing additional deterioration of health in these complex patients (15) (16) (17) (18) .
Antidepressants have many indications and are frequently prescribed to neurological patients (22) . It is not surprising that patients who are prescribed antidepressants have a higher risk of potential DDIs since the majority of antidepressant drugs are substrates for one or more of the cytochrome P-450 isozymes. Co-medication with inducers (e.g. carbamazepine or phenytoin) or inhibitors (e.g. valproate or imidazoles) may decrease or increase (50%-60%), respectively, serum concentrations of antidepressants such as amitriptyline and nortriptyline, affecting their efficacy and safety (23) . On the other hand, selective inhibitors of serotonin reuptake may interact pharmacodynamically with anticoagulant and antiplatelet drugs increasing the risk of bleeding (24) .
The number of prescribers per patient was a mitigating factor for a number of interactions not only in our study but also in the study conducted in the Netherlands by Vingerhoets and associates (25) . Nevertheless, yet in another study within the settings of general practice, Anderson et al. established that potential drug-drug interactions in primary health care arise more often when multiple prescribers are involved in the treatment of a single patient (26) .
This difference could be explained by the settings themselves, as in a hospital physicians communicate with each other directly while caring for patients, while in the primary care they work mostly in shifts and rarely meet next to the patient to discuss therapy.
It is not surprising that advanced age bears the higher risk for development of potential DDIs, as there are numerous reasons. Aging is associated with important changes in the metabolism of drugs: biochemical composition of tissues is different renal clearance is frequently reduced, the hepatic function is decreased, the physiological capacity of many organs is progressively diminished, and susceptibility to disease enhanced, with increased vulnerability. Polypharmacy is of great concern in elderly patients as it increases the frequency of adverse drug reactions, new hospital admissions and prolongs actual hospitalization (7) . From the Interestingly, in our study occurrence of serious or moderate potential DDI-s was less frequent in paralyzed patients and in patients bedridden for at least for one day of hospitalization. Protective role of these medical conditions was not described previously, but it could be explained by more attention that clinicians pay to patients unable to get out of the bed, which includes search for potential DDIs (25) .
Despite results of other studies, where the length of hospitalizations was favorable factor for occurrence of potential DDIs as in neurology as in other wards in our study that was not shown. (26) . These differences could be observed in light of modest sample size in our study, but choosing general ward of Neurology department we tried to provide representative population which could compare to other cohorts.
A lot of patients from our study sample was taking combination of non-steroidal antiinflammatory drugs (NSAIDs) and angiotensin-converting enzyme inhibitors (ACE-I).
NSAIDs inhibit cyclooxygenase, thus decreasing prostaglandin production; as a consequence, blood flow through afferent arteriole decreases and glomerular filtration falls.
On the other hand, inhibition of angiotensin II synthesis decreases vasoconstriction and blood pressure, which impairs renal blood flow and glomerular filtration. Ultimate result of combining ACE inhibitors and NSAIDs is decrease of glomerular filtration rate (27) .
Although this potential DDI was less frequent in our study than in the Romanian one, significant proportion of patients may experience decrease in renal function due to impaired perfusion of the kidneys (28) . Simultaneous administration of two NSAIDs is also a matter of concern, since every year, about 1% to 1.5% of patients taking NSAIDs experience severe GI side effects like perforation, ulcer or bleeding (29) .
Our study has several limitations related to modest sample size, use of just three instead of full battery of interaction checkers and technical availability of medical records of patients in only certain periods of year (two months in the spring, and two months in the fall). This could induce omitting some significant factors which also contribute to occurrence of potential DDI-s. Also, using these checkers we found a lot of potential DDIs which were only theoretically defined and their clinical importance was not verified. Strength of our 18 study was detailed, in-depth analysis of the patient files, with validation of extracted data, which increases reliability of the results.
In conclusion, frequency of potential DDIs among neurological patients is considerable and influenced to the largest extent by advanced age, co-morbidities, total number of prescribed drugs per patient and concomitant use of antidepressants. More prescribers per patient and medical conditions that make patients bedridden protect from occurrence of potential DDIs.
However, both physicians and pharmacists in hospitals should pay more attention to potential DDIs in order to early detect them which could contribute not only to prevent serious and/or irreversible consequences as also to preclude prolongation of hospital admission and additional increase costs of treatment of these patients.
